Nevirapine Sandoz

Nevirapine, the active ingredient in Nevirapine Sandoz, is a non‑nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral administration. It is indicated for the treatment of HIV‑1 infection in adults and adolescents, helping to suppress viral replication.

GNH USA supplies Nevirapine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring reliable quality, timely delivery and support for procurement teams.

Nevirapine is an antiretroviral drug that targets the HIV‑1 reverse transcriptase enzyme.

HIV‑1 infection: reduces viral replication and helps restore immune function in infected individuals.

Nevirapine may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Rash: mild to moderate skin eruptions. - Nausea: occasional gastrointestinal upset. - Fatigue: feeling of tiredness. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Hepatic failure: significant liver injury. - Hypersensitivity reactions: including fever and eosinophilia. - Neutropenia or anaphylaxis: rare but potentially life‑threatening.

When prescribing Nevirapine, clinicians should consider several safety and handling precautions. - Baseline liver function testing: assess hepatic enzymes before initiating therapy. - Monitor for rash: observe patients for skin reactions, especially during the first weeks. - Avoid use in patients with known hypersensitivity to NNRTIs. - Do not co‑administer with potent CYP3A4 inducers without dose adjustment. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nevirapine interacts with several medicines that affect its metabolism or increase toxicity risk.

Major Interactions (Avoid): - Ritonavir‑boosted protease inhibitors: may increase hepatotoxicity. - St. John’s wort: strong CYP3A4 inducer, reduces nevirapine levels. - Azole antifungals (e.g., ketoconazole): increase nevirapine concentrations, risk of toxicity.

Moderate Interactions (Monitor Closely): - Efavirenz: additive central nervous system effects. - Nephrotoxic drugs (e.g., tenofovir): monitor renal function. - Warfarin: may alter INR, requiring closer monitoring.